153 related articles for article (PubMed ID: 16410451)
1. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.
Kasyapa CS; Kunapuli P; Hawthorn L; Cowell JK
Blood; 2006 May; 107(9):3693-9. PubMed ID: 16410451
[TBL] [Abstract][Full Text] [Related]
2. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.
Kasyapa C; Gu TL; Nagarajan L; Polakiewicz R; Cowell JK
Proteomics; 2009 Aug; 9(16):3979-88. PubMed ID: 19658100
[TBL] [Abstract][Full Text] [Related]
4. ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.
Smedley D; Demiroglu A; Abdul-Rauf M; Heath C; Cooper C; Shipley J; Cross NC
Neoplasia; 1999 Oct; 1(4):349-55. PubMed ID: 10935490
[TBL] [Abstract][Full Text] [Related]
5. ZNF198 protein, involved in rearrangement in myeloproliferative disease, forms complexes with the DNA repair-associated HHR6A/6B and RAD18 proteins.
Kunapuli P; Somerville R; Still IH; Cowell JK
Oncogene; 2003 May; 22(22):3417-23. PubMed ID: 12776193
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
[TBL] [Abstract][Full Text] [Related]
7. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
Ren M; Li X; Cowell JK
Blood; 2009 Aug; 114(8):1576-84. PubMed ID: 19506298
[TBL] [Abstract][Full Text] [Related]
8. HSPA1A is an important regulator of the stability and function of ZNF198 and its oncogenic derivative, ZNF198-FGFR1.
Kasyapa CS; Kunapuli P; Cowell JK
J Cell Biochem; 2007 Dec; 102(5):1308-17. PubMed ID: 17471537
[TBL] [Abstract][Full Text] [Related]
9. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder.
Etienne A; Gelsi-Boyer V; Carbuccia N; Adélaïde J; Barba G; La Starza R; Murati A; Eclache V; Birg F; Birnbaum D; Mozziconacci MJ; Mecucci C; Chaffanet M
Cancer Genet Cytogenet; 2007 Mar; 173(2):154-8. PubMed ID: 17321332
[TBL] [Abstract][Full Text] [Related]
10. Critical role of STAT5 activation in transformation mediated by ZNF198-FGFR1.
Heath C; Cross NC
J Biol Chem; 2004 Feb; 279(8):6666-73. PubMed ID: 14660670
[TBL] [Abstract][Full Text] [Related]
11. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.
Reiter A; Sohal J; Kulkarni S; Chase A; Macdonald DH; Aguiar RC; Gonçalves C; Hernandez JM; Jennings BA; Goldman JM; Cross NC
Blood; 1998 Sep; 92(5):1735-42. PubMed ID: 9716603
[TBL] [Abstract][Full Text] [Related]
12. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
13. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
[TBL] [Abstract][Full Text] [Related]
14. Mass spectroscopy identifies the splicing-associated proteins, PSF, hnRNP H3, hnRNP A2/B1, and TLS/FUS as interacting partners of the ZNF198 protein associated with rearrangement in myeloproliferative disease.
Kasyapa CS; Kunapuli P; Cowell JK
Exp Cell Res; 2005 Sep; 309(1):78-85. PubMed ID: 15975576
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and gene involved of one case of 8p11 myeloproliferative syndrome with ins(13;8)(q12;p11p23)].
Zhou F; Chen S; Chao H; Zhang R; Zhou M; Pan J
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):291-6. PubMed ID: 25916288
[TBL] [Abstract][Full Text] [Related]
16. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
Ren M; Cowell JK
Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
[TBL] [Abstract][Full Text] [Related]
17. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function.
Dickinson JL; Bates EJ; Ferrante A; Antalis TM
J Biol Chem; 1995 Nov; 270(46):27894-904. PubMed ID: 7499264
[TBL] [Abstract][Full Text] [Related]
19. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
[TBL] [Abstract][Full Text] [Related]
20. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.
Xiao S; McCarthy JG; Aster JC; Fletcher JA
Blood; 2000 Jul; 96(2):699-704. PubMed ID: 10887137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]